Skip to content

Relmada Therapeutics, Inc. RLMD Effective Income Tax Rate Reconciliation, Other Adjustments, Amount

Effective Income Tax Rate Reconciliation, Other Adjustments, Amount at other companies

ServiceNow logo
ServiceNowNOW
-$500K-200%
Royal Caribbean Group logo
Royal Caribbean GroupRCL
-$250K
Imperial Oil logo
Imperial OilIMO
-$5.25M+60.4%
PNC Financial Services logo
PNC Financial ServicesPNC
-$5.25M-320%
TMC the metals company Inc. logo
TMC the metals company Inc.TMC
-$639.25K
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-0.8%

Other financials

Income statement

See full
Operating income-$19.5M-6.8%
Net income-$19.1M-8.5%
EPS (diluted)-$0.22+62.1%

Balance sheet

See full
Cash & equivalents$9.8M+750%
Total debt$104.1M-40.4%
Total equity$218.7M+875%
Total assets$235.4M+750%

Cash flow

See full
Operating cash flow-$15.1M+16.6%

Valuation

See full
Market cap$677.17M+2,907%

Returns & leverage

See full
Return on equity-48.8%-20.0pp
Debt / equity0.9×0.0×
Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationOtherAdjustments.

The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s effective income tax rate reconciliation, other adjustments, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s effective income tax rate reconciliation, other adjustments, amount?
Relmada Therapeutics, Inc. (RLMD) reported effective income tax rate reconciliation, other adjustments, amount of -$863.78K in Q4 2025.